Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7396)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2014 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tabrizian P, Roayaie S, Schwartz ME. Current management of hepatocellular carcinoma. World J Gastroenterol 2014; 20(30): 10223-10237 [PMID: 25132740 DOI: 10.3748/wjg.v20.i30.10223] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i30/10223.htm |
| Number | Citing Articles |
| 1 |
Qiaoyou Weng, Minjiang Chen, Maoquan Li, Yong-Fa Zheng, Guoliang Shao, Weijun Fan, Xi-Ming Xu, Jiansong Ji. Global microarray profiling identifiedhsa_circ_0064428as a potential immune-associated prognosis biomarker for hepatocellular carcinoma. Journal of Medical Genetics 2019; 56(1): 32 doi: 10.1136/jmedgenet-2018-105440
|
| 2 |
Flair J Carrilho, Angelo Alves de Mattos, Alex F Vianey, Denise Cerqueira P Vezozzo, Fábio Marinho, Francisco J Souto, Helma P Cotrim, Henrique Sergio M Coelho, Ivonete Silva, José Huygens P Garcia, Luciana Kikuchi, Patricia Lofego, Wellington Andraus, Edna Strauss, Giovanni Silva, Isaac Altikes, Jose Eymard Medeiros, Paulo L Bittencourt, Edison R Parise. Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma. Arquivos de Gastroenterologia 2015; 52(suppl 1): 2 doi: 10.1590/s0004-28032015000500001
|
| 3 |
Yanxia Gong, Xiang Wu, Tao Wang, Jia Zhao, Xi Liu, Zhi Yao, Qingyu Zhang, Xu Jian. Targeting PEPT1: a novel strategy to improve the antitumor efficacy of doxorubicin in human hepatocellular carcinoma therapy. Oncotarget 2017; 8(25): 40454 doi: 10.18632/oncotarget.17117
|
| 4 |
YANG GAO, YAYUN ZHU, XINYU HUANG, KAIXING AI, QI ZHENG, ZHOU YUAN. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA. International Journal of Oncology 2015; 47(2): 668 doi: 10.3892/ijo.2015.3047
|
| 5 |
Prachi Anand, Petr Filipenko, Jeannette Huaman, Michael Lyudmer, Marouf Hossain, Carolina Santamaria, Kelly Huang, Olorunseun O. Ogunwobi, Mandë Holford. Selective Inhibition of Liver Cancer Cells Using Venom Peptide. Marine Drugs 2019; 17(10): 587 doi: 10.3390/md17100587
|
| 6 |
Shen Hu, Yan Zhu, Xiangyang Xia, Xiaobo Xu, Fen Chen, Xudong Miao, Xinmei Chen. Ginsenoside Rg3 Prolongs Survival of the Orthotopic Hepatocellular Carcinoma Model by Inducing Apoptosis and Inhibiting Angiogenesis. Analytical Cellular Pathology 2019; 2019: 1 doi: 10.1155/2019/3815786
|
| 7 |
Jinn-Rung Kuo, Hung-Sheng Shang, Chun-Te Ho, Kun-Goung Lai, Tsan-Zon Liu, Yin-Ju Chen, Jeng-Fong Chiou. Cisplatin-induced regulation of signal transduction pathways and transcription factors in p53-mutated subclone variants of hepatoma cells: Potential application for therapeutic targeting. Oncology Letters 2016; 12(5): 3723 doi: 10.3892/ol.2016.5181
|
| 8 |
Weisheng Guo, Lin Zhao, Guangya Wei, Peng Liu, Yu Zhang, Liran Fu. <p>Circ_0015756 Aggravates Hepatocellular Carcinoma Development by Regulating FGFR1 via Sponging miR-610</p>. Cancer Management and Research 2020; : 7383 doi: 10.2147/CMAR.S262231
|
| 9 |
Zhan-Hong Chen, Ying-Fen Hong, Jinxiang Lin, Xing Li, Dong-Hao Wu, Jing-Yun Wen, Jie Chen, Dan-Yun Ruan, Qu Lin, Min Dong, Li Wei, Tian-Tian Wang, Ze-Xiao Lin, Xiao-Kun Ma, Xiang-Yuan Wu, Ruihua Xu. Validation and ranking of seven staging systems of hepatocellular carcinoma. Oncology Letters 2017; 14(1): 705 doi: 10.3892/ol.2017.6222
|
| 10 |
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, NAOKI ISHIGE. Niclosamide suppresses migration of hepatocellular carcinoma cells and downregulates matrix metalloproteinase-9 expression. Oncology Letters 2015; 10(6): 3515 doi: 10.3892/ol.2015.3789
|
| 11 |
Isabel Fabregat, Daniel Caballero-Díaz. Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00357
|
| 12 |
Aline Lopes CHAGAS, Angelo Alves de MATTOS, Flair José CARRILHO, Paulo Lisboa BITTENCOURT, Denise Cerqueira Paranaguá VEZOZZO, Natally HORVAT, Manoel de Souza ROCHA, Venâncio Avancini Ferreira ALVES, Gabriela Perdomo CORAL, Mario Reis ALVARES-DA-SILVA, Fabio Marinho do Rego BARROS, Marcos Roberto MENEZES, Lucas Moretti MONSIGNORE, Fabricio Ferreira COELHO, Renato Ferreira da SILVA, Rita de Cássia Martins Alves SILVA, Ilka de Fatima Santana Ferreira BOIN, Luiz Augusto Carneiro D`ALBUQUERQUE, José Huygens Parente GARCIA, Guilherme Eduardo Gonçalves FELGA, Airton Mota MOREIRA, Maria Ignez Freitas Melro BRAGHIROLI, Paulo Marcelo Gehm HOFF, Vivianne Barretto de MELLO, Mariana Fonseca DOTTORI, Tiago Pugliese BRANCO, Leonardo de Lucca SCHIAVON, Thaisa de Fátima Almeida COSTA. BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA. Arquivos de Gastroenterologia 2020; 57(suppl 1): 1 doi: 10.1590/s0004-2803.202000000-20
|
| 13 |
G.P. Rajalekshmy, Rajan Annie Mariya, M.R. Rekha. Biopolymer-Based Nanomaterials in Drug Delivery and Biomedical Applications. 2021; : 383 doi: 10.1016/B978-0-12-820874-8.00010-5
|
| 14 |
Tatyana Kushner, Douglas Dieterich, Behnam Saberi. Direct-acting antiviral treatment for patients with hepatocellular carcinoma. Current Opinion in Gastroenterology 2018; 34(3): 132 doi: 10.1097/MOG.0000000000000431
|
| 15 |
Jean-Louis Bayart, Antoine Mairesse, Damien Gruson, Marie-Astrid van Dievoet. Analytical performances and biological variation of PIVKA-II (des-y-carboxy-prothrombin) in European healthy adults. Clinica Chimica Acta 2020; 509: 264 doi: 10.1016/j.cca.2020.06.035
|
| 16 |
Kenya Kamimura, Takeshi Suda, Takeshi Yokoo, Hiroteru Kamimura, Tsutomu Kanefuji, Atsunori Tsuchiya, Masaaki Takamura, Hirokazu Kawai, Nobuo Waguri, Satoshi Yamagiwa, Shuji Terai. Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3320-7
|
| 17 |
Qing Zhao, Bo Zheng, Shiquan Meng, Ying Xu, Jing Guo, Li-jie Chen, Jian Xiao, Wei Zhang, Zhi-rong Tan, Jie Tang, Lei Chen, Yao Chen. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy. Biomedicine & Pharmacotherapy 2019; 114: 108864 doi: 10.1016/j.biopha.2019.108864
|
| 18 |
Shazia Tabasum, Aqdas Noreen, Muhammad Farzam Maqsood, Hijab Umar, Nadia Akram, Zill-i-Huma Nazli, Shahzad Ali Shahid Chatha, Khalid Mahmood Zia. A review on versatile applications of blends and composites of pullulan with natural and synthetic polymers. International Journal of Biological Macromolecules 2018; 120: 603 doi: 10.1016/j.ijbiomac.2018.07.154
|
| 19 |
Kyeong Hwa Sim, Mi-Sun Shu, Soyoung Kim, Jong-Yeon Kim, Bo-Hyun Choi, Youn Ju Lee. Cilostazol Induces Apoptosis and Inhibits Proliferation of Hepatocellular Carcinoma Cells by Activating AMPK. Biotechnology and Bioprocess Engineering 2021; 26(5): 776 doi: 10.1007/s12257-021-0002-8
|
| 20 |
C. Rory Goodwin, Vijay Yanamadala, Alejandro Ruiz-Valls, Nancy Abu-Bonsrah, Ganesh Shankar, Eric W. Sankey, Christine Boone, Michelle J. Clarke, Mark Bilsky, Ilya Laufer, Charles Fisher, John H. Shin, Daniel M. Sciubba. A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine. World Neurosurgery 2016; 91: 510 doi: 10.1016/j.wneu.2016.04.026
|
| 21 |
Chun-Te Ho, Yu-Jia Chang, Li-Xi Yang, Po-Li Wei, Tsan-Zon Liu, Jun-Jen Liu, Yi-Hsien Hsieh. A Novel Microtubule-Disrupting Agent Induces Endoplasmic Reticular Stress-Mediated Cell Death in Human Hepatocellular Carcinoma Cells. PLOS ONE 2015; 10(9): e0136340 doi: 10.1371/journal.pone.0136340
|
| 22 |
Ning Bai, Eming Peng, Xingsheng Qiu, Ning Lyu, Zhejia Zhang, Yiming Tao, Xinying Li, Zhiming Wang. circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0838-8
|
| 23 |
David J. Pinato, Matthew W. Brown, Sebastian Trousil, Eric O. Aboagye, Jamie Beaumont, Hua Zhang, Helen M. Coley, Francesco A. Mauri, Rohini Sharma. Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma. British Journal of Cancer 2019; 120(5): 512 doi: 10.1038/s41416-018-0373-6
|
| 24 |
Ajalaya Teyateeti, Armeen Mahvash, James Long, Mohamed Abdelsalam, Rony Avritscher, Ahmed Kaseb, Bruno Odisio, Gregory Ravizzini, Devaki Surasi, Achiraya Teyateeti, Homer Macapinlac, Srinivas Cheenu Kappadath. Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib. World Journal of Gastroenterology 2021; 27(47): 8166-8181 doi: 10.3748/wjg.v27.i47.8166
|
| 25 |
Da-wei Sun, Ying-yi Zhang, Xiao-dong Sun, Yu-guo Chen, Wei Qiu, Min Ji, Guo-yue Lv. Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysis. Clinica Chimica Acta 2015; 448: 161 doi: 10.1016/j.cca.2015.06.027
|
| 26 |
Robert R. McMillan, Vatche G. Agopian. The Critically Ill Cirrhotic Patient. 2020; : 237 doi: 10.1007/978-3-030-24490-3_13
|
| 27 |
Jelena Marinić, Dalibor Broznić, Čedomila Milin, Ilaria Peluso. Preexposure to Olive Oil Polyphenols Extract Increases Oxidative Load and Improves Liver Mass Restoration after Hepatectomy in Mice via Stress‐Sensitive Genes. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/9191407
|
| 28 |
Cong Zhang, Tong An, Dan Wang, Guoyun Wan, Mingming Zhang, Hemei Wang, Sipei Zhang, Rongshan Li, Xiaoying Yang, Yinsong Wang. Stepwise pH-responsive nanoparticles containing charge-reversible pullulan-based shells and poly(β-amino ester)/poly(lactic-co-glycolic acid) cores as carriers of anticancer drugs for combination therapy on hepatocellular carcinoma. Journal of Controlled Release 2016; 226: 193 doi: 10.1016/j.jconrel.2016.02.030
|
| 29 |
Nicolae Arsenii, Tullio Piardi, Marie-Danièle Diébold, Marie-Pierrette Chenard, Moustapha Drame, Louis De Mestier, Christine Hoeffel, Patrick Pessaux, Daniele Sommacale, Gérard Thiéfin. Impact of Visceral Obesity on Microvascular Invasion in Hepatocellular Carcinoma. Cancer Investigation 2016; 34(6): 271 doi: 10.1080/07357907.2016.1193747
|
| 30 |
Hongping Lu, Ming Han, Xiaoxue Yuan, Kelbinur Tursun, Yu Zhang, Yaru Li, Zhongshu Li, Shenghu Feng, Li Zhou, Zhipeng Pan, Qi Wang, Kai Han, Shunai Liu, Jun Cheng. Role of IL‐6‐mediated expression of NS5ATP9 in autophagy of liver cancer cells. Journal of Cellular Physiology 2018; 233(12): 9312 doi: 10.1002/jcp.26343
|
| 31 |
|
| 32 |
Chun-Te Ho, Hung-Sheng Shang, Jin-Biou Chang, Jun-Jen Liu, Tsan-Zon Liu. Folate deficiency-triggered redox pathways confer drug resistance in hepatocellular carcinoma. Oncotarget 2015; 6(28): 26104 doi: 10.18632/oncotarget.4422
|
| 33 |
Yunwu Wang, Yu Xu, Wei Yan, Ping Han, Jingmei Liu, Jin Gong, Dongxiao Li, Xiangming Ding, Han Wang, Zhuoying Lin, Dean Tian, Jiazhi Liao. CFIm25 inhibits hepatocellular carcinoma metastasis by suppressing the p38 and JNK/c-Jun signaling pathways. Oncotarget 2018; 9(14): 11783 doi: 10.18632/oncotarget.24364
|
| 34 |
Abdulrahman Al-Shami, Rami Joseph Oweis, Mohamed Ghazi Al-Fandi. Developing an electrochemical immunosensor for early diagnosis of hepatocellular carcinoma. Sensor Review 2021; 41(2): 125 doi: 10.1108/SR-02-2020-0030
|
| 35 |
Jingxiong Lu, Jin Wang, Daishun Ling. Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma. Small 2018; 14(5) doi: 10.1002/smll.201702037
|
| 36 |
Ajalaya Teyateeti, Armeen Mahvash, James P Long, Mohamed E Abdelsalam, Rony Avritscher, Beth Chasen, Ahmed O Kaseb, Joshua D Kuban, Ravi Murthy, Bruno C Odisio, Achiraya Teyateeti, Homer A Macapinlac, S. Cheenu Kappadath. <p>Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients</p>. Journal of Hepatocellular Carcinoma 2020; : 117 doi: 10.2147/JHC.S248314
|
| 37 |
Bachir Taouli, Ahmed Ba-Ssalamah, Julius Chapiro, Jagpreet Chhatwal, Kathryn Fowler, Tae Wook Kang, Gesine Knobloch, Dow-Mu Koh, Masatoshi Kudo, Jeong Min Lee, Takamichi Murakami, David J. Pinato, Kristina I. Ringe, Bin Song, Parissa Tabrizian, Jin Wang, Jeong Hee Yoon, Mengsu Zeng, Jian Zhou, Valérie Vilgrain. Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussion. European Radiology 2023; 33(12): 9167 doi: 10.1007/s00330-023-09919-z
|
| 38 |
Magdy Fouad, Mohamed El Kassas, Elham Ahmed, Reem El Sheemy. Tumor characteristics of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C: Comparative analysis with antiviral therapy-naive patients. World Journal of Hepatology 2021; 13(11): 1743-1752 doi: 10.4254/wjh.v13.i11.1743
|
| 39 |
V. Behrana Jensen, Suzanne L. Craig. Locoregional Radionuclide Cancer Therapy. 2021; : 189 doi: 10.1007/978-3-030-56267-0_9
|
| 40 |
Elise Verger, Pierre Drion, Geneviève Meffre, Claire Bernard, Luc Duwez, Nicolas Lepareur, Olivier Couturier, François Hindré, Roland Hustinx, Franck Lacoeuille, Hélder A. Santos. 68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies. PLOS ONE 2016; 11(10): e0164626 doi: 10.1371/journal.pone.0164626
|
| 41 |
Shu-Ye Liu. Role of exosomes in pathogenesis, progression, diagnosis and treatment of hepatocellular carcinoma. World Chinese Journal of Digestology 2019; 27(5): 330 doi: 10.11569/wcjd.v27.i5.330
|
| 42 |
Behnam Saberi, Hetanshi Naik, Jessica R. Overbey, Angelika L. Erwin, Karl E. Anderson, D. Montgomery Bissell, Herbert L. Bonkovsky, John D. Phillips, Bruce Wang, Ashwani K.Singal, Brendan M.McGuire, Robert J. Desnick, Manisha Balwani. Hepatocellular Carcinoma in Acute Hepatic Porphyrias: Results from the Longitudinal Study of the U.S. Porphyrias Consortium. Hepatology 2021; 73(5): 1736 doi: 10.1002/hep.31460
|
| 43 |
Lin Chen, Haitao Guan, Chunyan Gu, Yali Cao, Jianguo Shao, Feng Wang. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL. Tumor Biology 2016; 37(2): 2497 doi: 10.1007/s13277-015-4071-1
|
| 44 |
Xiao-Jun Feng, Qing Pan, Shou-Mei Wang, Yun-cui Pan, Qian Wang, Huan-Huan Zhang, Ming-Hua Zhu, Shu-Hui Zhang. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma. Tumor Biology 2016; 37(8): 11457 doi: 10.1007/s13277-016-5022-1
|
| 45 |
Xiaoyang Liu, Nicholas Ellens, Emery Williams, Everette C. Burdette, Parag Karmarkar, Clifford R. Weiss, Dara Kraitchman, Paul A. Bottomley. High‐resolution intravascular MRI‐guided perivascular ultrasound ablation. Magnetic Resonance in Medicine 2020; 83(1): 240 doi: 10.1002/mrm.27932
|
| 46 |
Danijel Galun, Dragan Basaric, Marinko Zuvela, Predrag Bulajic, Aleksandar Bogdanovic, Nemanja Bidzic, Miroslav Milicevic. Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World Journal of Hepatology 2015; 7(20): 2274-2291 doi: 10.4254/wjh.v7.i20.2274
|